Globus Medical (NYSE:GMED) — Market Cap & Net Worth
Market Cap & Net Worth: Globus Medical (GMED)
Globus Medical (NYSE:GMED) has a market capitalization of $9.13 Billion ($9.13 Billion) as of August 7, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #2407 globally and #879 in its home market, demonstrating a -0.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Globus Medical's stock price $80.54 by its total outstanding shares 113314529 (113.31 Million). See Globus Medical capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Globus Medical Market Cap History: 2015 to 2026
Globus Medical's market capitalization history from 2015 to 2026. Data shows growth from $3.15 Billion to $9.13 Billion (12.19% CAGR).
Index Memberships
Globus Medical is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.50 Trillion | 0.32% | #140 of 401 |
Weight: Globus Medical's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Globus Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Globus Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.37x
Globus Medical's market cap is 3.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.39x
Globus Medical's market cap is 18.39 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.81 Billion | $563.99 Million | $104.34 Million | 4.98x | 26.94x |
| 2017 | $4.66 Billion | $635.98 Million | $107.35 Million | 7.32x | 43.38x |
| 2018 | $4.90 Billion | $712.97 Million | $156.47 Million | 6.88x | 31.34x |
| 2019 | $6.67 Billion | $785.37 Million | $155.21 Million | 8.50x | 42.99x |
| 2020 | $7.39 Billion | $789.04 Million | $102.28 Million | 9.37x | 72.25x |
| 2021 | $8.18 Billion | $958.10 Million | $149.19 Million | 8.54x | 54.84x |
| 2022 | $8.42 Billion | $1.02 Billion | $190.17 Million | 8.23x | 44.25x |
| 2023 | $6.04 Billion | $1.57 Billion | $122.87 Million | 3.85x | 49.14x |
| 2024 | $9.37 Billion | $2.52 Billion | $102.98 Million | 3.72x | 91.01x |
| 2025 | $9.89 Billion | $2.94 Billion | $537.90 Million | 3.37x | 18.39x |
Competitor Companies of GMED by Market Capitalization
Companies near Globus Medical in the global market cap rankings as of August 7, 2026.
Key companies related to Globus Medical by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #117 globally with a market cap of $183.82 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #184 globally with a market cap of $128.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #240 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #117 | Abbott Laboratories | NYSE:ABT | $183.82 Billion | $105.71 |
| #184 | Stryker Corporation | NYSE:SYK | $128.98 Billion | $337.03 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.99 |
Globus Medical Historical Marketcap From 2015 to 2026
Between 2015 and today, Globus Medical's market cap moved from $3.15 Billion to $ 9.13 Billion, with a yearly change of 12.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $9.13 Billion | -7.75% |
| 2025 | $9.89 Billion | +5.56% |
| 2024 | $9.37 Billion | +55.21% |
| 2023 | $6.04 Billion | -28.25% |
| 2022 | $8.42 Billion | +2.87% |
| 2021 | $8.18 Billion | +10.70% |
| 2020 | $7.39 Billion | +10.77% |
| 2019 | $6.67 Billion | +36.04% |
| 2018 | $4.90 Billion | +5.30% |
| 2017 | $4.66 Billion | +65.66% |
| 2016 | $2.81 Billion | -10.82% |
| 2015 | $3.15 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Globus Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.13 Billion USD |
| MoneyControl | $9.13 Billion USD |
| MarketWatch | $9.13 Billion USD |
| marketcap.company | $9.13 Billion USD |
| Reuters | $9.13 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more